Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Completeness and quality of low back pain prevalence data in the Global Burden of Disease Study 2017.

Tytuł:
Completeness and quality of low back pain prevalence data in the Global Burden of Disease Study 2017.
Autorzy:
Tamrakar M; Institute for Musculoskeletal Health, The University of Sydney, Sydney, New South Wales, Australia.
Kharel P; Institute for Musculoskeletal Health, The University of Sydney, Sydney, New South Wales, Australia.
Traeger A; Institute for Musculoskeletal Health, The University of Sydney, Sydney, New South Wales, Australia.
Maher C; Institute for Musculoskeletal Health, The University of Sydney, Sydney, New South Wales, Australia .
O'Keeffe M; Institute for Musculoskeletal Health, The University of Sydney, Sydney, New South Wales, Australia.
Ferreira G; Institute for Musculoskeletal Health, The University of Sydney, Sydney, New South Wales, Australia.
Źródło:
BMJ global health [BMJ Glob Health] 2021 May; Vol. 6 (5).
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: [London] : BMJ Publishing Group Ltd, [2016]-
MeSH Terms:
Global Burden of Disease*
Low Back Pain*/epidemiology
Global Health ; Humans ; Income ; Prevalence
References:
Lancet. 2020 Oct 17;396(10258):1135-1159. (PMID: 33069324)
Lancet Glob Health. 2015 Nov;3(11):e712-23. (PMID: 26475018)
Rheumatology (Oxford). 2021 Jan 25;:. (PMID: 33493285)
BMC Musculoskelet Disord. 2018 Aug 16;19(1):292. (PMID: 30115055)
Ann Transl Med. 2020 Mar;8(6):299. (PMID: 32355743)
Eur J Pain. 2010 Aug;14(7):747.e1-7. (PMID: 20036168)
Lancet. 2018 Jun 9;391(10137):2356-2367. (PMID: 29573870)
Lancet. 2018 Nov 10;392(10159):1859-1922. (PMID: 30415748)
Lancet. 2018 Jun 9;391(10137):2384-2388. (PMID: 29573871)
Lancet. 2020 Oct 17;396(10258):1204-1222. (PMID: 33069326)
Contributed Indexing:
Keywords: arthritis; indices of health and disease and standardisation of rates; public Health
Entry Date(s):
Date Created: 20210518 Date Completed: 20210624 Latest Revision: 20210624
Update Code:
20240104
PubMed Central ID:
PMC8130740
DOI:
10.1136/bmjgh-2021-005847
PMID:
34001521
Czasopismo naukowe
Introduction: Completeness of Global Burden of Disease (GBD) Study data is acknowledged as a limitation. To date, no study has evaluated this issue for low back pain, a leading contributor to disease burden globally.
Methods: We retrieved reports, in any language, based on citation details from the GBD 2017 study website. Pairs of raters independently extracted the following data: number of prevalence reports tallied across countries, age groups, gender and years from 1987 to 2017. We also considered if studies enrolled a representative sample and/or used an acceptable measure of low back pain.
Results: We retrieved 488 country-level reports that provide prevalence data for 103 of 204 countries (50.5%), with most prevalence reports (61%) being for high-income countries. Only 16 countries (7.8%) have prevalence reports for each of the three decades of the GBD. Most of the reports (79%) did not use an acceptable measure of low back pain when estimating prevalence.
Conclusion: We found incomplete coverage across countries and time, and limitations in the primary prevalence studies included in the GBD 2017 study. This means there is considerable uncertainty about GBD estimates of low back pain prevalence and the disease burden metrics derived from prevalence.
Competing Interests: Competing interests: AT reports he has received research grants from numerous Government and not for profit agencies outside the submitted work. CM reports he has received research grants from numerous Government and not for profit agencies outside the submitted work. His expenses have been covered by professional associations hosting conferences he has spoken at. Flexeze provide heat wraps at no cost for the SHaPED trial that he is an investigator on. MO received a Marie Curie Fellowship from the European Commission from 2018 to 2020, outside the submitted work. MT has nothing to disclose. Kharel has nothing to disclose. GF has nothing to disclose
(© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies